share_log

智飞生物(300122.SZ):目前共有13种产品上市在售

Chongqing Zhifei Biological Products (300122.SZ): Currently, there are 13 products listed and available for sale.

Gelonghui Finance ·  Aug 9 05:31

Chongqing Zhifei Biological Products (300122.SZ) stated on the investor interaction platform that the company currently has 13 products on the market, 1 product has conditional approval, including vaccines for infectious diseases such as meningitis, cervical cancer, pneumonia, rotavirus, and herpes zoster, as well as pharmaceuticals that provide effective solutions for tuberculosis infection diagnosis, prevention, and treatment, covering populations including infants, adolescents, and adults. At the same time, one product is in the stage of applying for market approval, two products have completed clinical trials, and six products are in phase III clinical trials. The company's extensive marketing network can enable professional services from the marketing team to reach more areas, allowing more people to benefit from higher quality vaccine products and continuously enhance vaccine accessibility.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment